EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cancer‐associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma

Jaakko S Knuutila iD, Pilvi Riihilä iD, Liisa Nissinen iD, Lauri Heiskanen iD, Roosa E Kallionpää iD, Teijo Pellinen iD, Veli-Matti Kähäri iD

International Journal of Cancer · 15.09.2024 · 155 (6) · 1112-1127

DOI: 10.1002/ijc.34957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 22.04.2024. Verfasst von Jaakko S Knuutila und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland. Hauptthemen laut MEDLINE: Skin Neoplasms, Carcinoma, Squamous Cell, Cancer-Associated Fibroblasts, Disease Progression. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Varsinais-Suomen Sairaanhoitopiiri, Suomen Lääketieteen Säätiö, Sigrid Juséliuksen Säätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer and the metastatic disease is associated with poor prognosis. Cancer‐associated fibroblasts (CAFs) promote progression of cancer, but their role in cSCC is largely unknown. We examined the potential of CAF markers in the assessment of metastasis risk and prognosis of primary cSCC. We utilized multiplexed fluorescence immunohistochemistry for profiling CAF landscape in metastatic and non‐metastatic primary human cSCCs, in metastases, and in premalignant epidermal lesions. Quantitative high‐resolution image analysis was performed with two separate panels of antibodies for CAF markers and results were correlated with clinical and histopathological parameters including disease‐specific mortality. Increased stromal expression of fibroblast activation protein (FAP), α‐smooth muscle actin, and secreted protein acidic and rich in cysteine (SPARC) were associated with progression to invasive cSCC. Elevation of FAP and platelet‐derived growth factor receptor‐β (PDGFRβ) expression was associated with metastasis risk of primary cSCCs. High expression of PDGFRβ and periostin correlated with poor prognosis. Multimarker combination defined CAF subset, PDGFRα−/PDGFRβ+/FAP+, was associated with invasion and metastasis, and independently predicted poor disease‐specific survival. These results identify high PDGFRβ expression alone and multimarker combination PDGFRα−/PDGFRβ+/FAP+ by CAFs as potential biomarkers for risk of metastasis and poor prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsCarcinoma, Squamous CellCancer-Associated FibroblastsDisease ProgressionSerine EndopeptidasesReceptor, Platelet-Derived Growth Factor betaMembrane ProteinsHumansPrognosisFemaleMaleBiomarkers, TumorGelatinasesEndopeptidasesCell Adhesion MoleculesOsteonectinNeoplasm MetastasisReceptor, Platelet-Derived Growth Factor alphaAgedActinsMiddle AgedFibroblast Activation Protein Alpha

Stichwörter der Autor:innen

epidermolysis bullosafibroblastmetastasissquamous cell carcinoma

Substanzen

Serine EndopeptidasesReceptor, Platelet-Derived Growth Factor betaMembrane ProteinsBiomarkers, TumorGelatinasesEndopeptidasesCell Adhesion MoleculesOsteonectinReceptor, Platelet-Derived Growth Factor alphaActins

Autor:innen und Institutionen

  • Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland.
  • FICAN West Cancer Research Laboratory, University of Turku and Turku University Hospital, Turku, Finland.
  • Auria Biobank, Turku University Hospital and University of Turku, Turku, Finland.
  • Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), Helsinki, Finland.

ORCID-Profile: Jaakko S Knuutila, Pilvi Riihilä, Liisa Nissinen, Lauri Heiskanen, Roosa E Kallionpää, Teijo Pellinen, Veli-Matti Kähäri

Förderung

  • Varsinais-Suomen Sairaanhoitopiiri
  • Suomen Lääketieteen Säätiö
  • Sigrid Juséliuksen Säätiö
  • Maud Kuistilan Muistosäätiö
  • Syöpäsäätiö
  • Jane ja Aatos Erkon Säätiö
  • Suomen Ihotautilääkäriyhdistys
  • Lounais-Suomen Syöpäyhdistys

Zitieren

APA

Knuutila, J. S., Riihilä, P., Nissinen, L., Heiskanen, L., Kallionpää, R. E., Pellinen, T., & Kähäri, V. M. (2024). Cancer‐associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma. International Journal of Cancer, 155(6), 1112-1127. https://doi.org/10.1002/ijc.34957

Vancouver

Knuutila JS, Riihilä P, Nissinen L, Heiskanen L, Kallionpää RE, Pellinen T, et al. Cancer‐associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma. International Journal of Cancer. 2024;155(6):1112-1127. doi:10.1002/ijc.34957

BibTeX
@article{Knuutila2024,
  author = {Knuutila, Jaakko S and Riihilä, Pilvi and Nissinen, Liisa and Heiskanen, Lauri and Kallionpää, Roosa E and Pellinen, Teijo and Kähäri, Veli-Matti},
  title = {Cancer‐associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma},
  journal = {International Journal of Cancer},
  year = {2024},
  volume = {155},
  number = {6},
  pages = {1112--1127},
  doi = {10.1002/ijc.34957}
}
Kostenlos starten →